AnuMed Draws Warning Letter for Unapproved Products, Including Semaglutide

The FDA hit AnuMed International with a Warning Letter for marketing multiple unapproved drugs including a “homeopathic” semaglutide for weight loss.
Source: Drug Industry Daily